Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Option Care Health (OPCH) Receivables (2016 - 2026)

Option Care Health (OPCH) has disclosed Receivables for 18 consecutive years, with $142.9 billion as the latest value for Q1 2026.

  • For Q1 2026, Receivables rose 29883.58% year-over-year to $142.9 billion; the TTM value through Mar 2026 reached $142.9 billion, up 29883.58%, while the annual FY2025 figure was $155.6 billion, 30106.52% up from the prior year.
  • Receivables hit $142.9 billion in Q1 2026 for Option Care Health, down from $155.6 billion in the prior quarter.
  • Across five years, Receivables topped out at $155.6 billion in Q4 2025 and bottomed at $362.8 million in Q2 2022.
  • Average Receivables over 5 years is $17.9 billion, with a median of $468.6 million recorded in 2024.
  • On a YoY basis, Receivables climbed as much as 30106.52% in 2025 and fell as far as 17.05% in 2025.
  • Option Care Health's Receivables stood at $479.0 million in 2022, then decreased by 2.56% to $466.8 million in 2023, then increased by 10.34% to $515.0 million in 2024, then surged by 30106.52% to $155.6 billion in 2025, then fell by 8.14% to $142.9 billion in 2026.
  • According to Business Quant data, Receivables over the past three periods came in at $142.9 billion, $155.6 billion, and $475.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.